A randomized, double-blind, parallel-controlled, multi-center clinical trial of traditional Chinese medicine variety protection with Wuhu Oral Liquid in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)

INTERVENTION: test group:Wuhu Oral Liquid; control group :Fufang Shangtong Capsules; CONDITION: acute soft tissue injury PRIMARY OUTCOME: Activity pain VAS score change value;Resting pain VAS score change;Therapeutic effect of TCM single symptom; SECONDARY OUTCOME: Therapeutic effects of TCM syndromes;Changes in the measured value of CRP;Time to disappearance of pain at rest and pain with activity (days);Changes in the measured value of interleukin‐6;Changes in VAS scores of resting pain and active pain within 0.5 hours of first administration; INCLUSION CRITERIA: (1) Meet the diagnostic criteria for acute soft tissue injury in Western medicine; (2) Comply with the standard of TCM syndrome differentiation of qi stagnation and blood stasis; (3) The duration of soft tissue injury is less than or equal to 48 hours; (4) VAS score of resting pain score of the affected area is more than 3 points, and activity pain is less than 9 points; (5) Age 18 to 65 years old (including 18 and 65 years old), gender is not limited; (6) Subjects gave informed consent, voluntarily tested and signed the informed consent form.